I’m Nastassia

I specialise in bridging the gap between product vision and user experience.

How I prevent organisations from building the wrong thing.

Regulated domains

A lot of my work sits where a wrong answer costs more than a bad review: cell and gene therapy supply chains, legal and compliance AI, pricing data sold to carmakers. So I design for traceability, clear permissions, and answers that show where they came from.

HIPAA (Health Insurance Portability and Accountability Act)FDA 21 CFR Part 11 (Electronic Records and Electronic Signatures)ISO 13485:2016 (Medical Devices Quality Management System)DSCSA (Drug Supply Chain Security Act)EU AI Act (EU Artificial Intelligence Act, Regulation (EU) 2024/1689)ISO/IEC 42001:2023 (Artificial Intelligence Management System)NIST AI RMF (NIST AI Risk Management Framework)IEEE 7000 Series (Standards for ethically aligned design in autonomous and intelligent systems)OSHA (Occupational Safety and Health Administration)FCPA (Foreign Corrupt Practices Act (anti-bribery))ISO 37001:2016 (Anti-Bribery Management Systems)ISO 31000:2018 (Risk Management Guidelines)SOC 2 (Service Organization Control 2 (SSAE 18, AICPA AT-C Section 205))GDPR (General Data Protection Regulation (EU 2016/679))BRAO (Bundesrechtsanwaltsordnung, the Federal Lawyers’ Act (Germany))EU CSDDD (Corporate Sustainability Due Diligence Directive)EU CSRD (Corporate Sustainability Reporting Directive)
AI products

I started designing AI products at Bryter in early 2023, a few months after ChatGPT turned AI into something companies could buy. Policy AI for compliance teams came first and won 5 paying customers. By July 2024 we had AI Agents live with customers, each one specialised in a single regulation, before “agents” became the word everyone uses. Then a Contract Agent for legal teams.

AI changed how fast we can build, not what’s worth building.

I focus on what decides whether people trust it at work: answers grounded in their own documents, sources you can check, feedback on every answer, and clear rules on who sees what.

AI agentsGrounded answersAI since 2023
Discovery & strategy

I go to the source. I sit in the prospect calls myself instead of reading the notes afterwards, write down the team’s assumptions before research, and test with the cheapest thing that answers the question: a smoke test, a mocked page, a prototype used as a sales demo. Sometimes the best result is killing an idea early.

Assumption mappingProspect discoveryPrototype-led tests
Product management

I’ve owned roadmaps at Babbel and Körber Digital, and stepped into the PM seat when a team needed someone to steer. I prioritise from evidence (plus a healthy dose of judgement), and I bring engineers into discovery early, so they own the outcome and not just the tickets.

RoadmapsPrioritisationCross-functional delivery
Systemic thinking & complexity

Products with many parties and many rules: 4 organisations sharing one patient record, forecasting and pricing teams who must not block each other, AI answers that depend on who’s allowed to see what. My job is to make each new piece fit the whole, so the product still feels like one product.

Information architectureRoles & permissionsMulti-party workflows
Building something that has to be right?Let’s talk

How I work
in practice.

Three case studies, including the parts that didn’t work.
Everything else lives under Experience.

01

Prototyping AI agents for compliance teams that turned 30 trials into 5 paying customers and a Product of the Year shortlist

A product nobody was pulling for, a pivot into AI for compliance, 30 trials and 5 paying customers, then back to legal when the data said so.

Regulated · Legal & GRCAIB2B SaaSScale-up
02

Testing 5 low-cost concepts for language learners who couldn’t travel, leading to a 2024 Webby-honoured audio adventure

When the pandemic stopped language trips, I moved from designer to product manager and ran a 3-month plan of cheap tests. One of the ideas became a Webby-honoured audio series.

EdTechB2CScale-up
03

Shadowing cell and gene therapy teams for 5 days to frame a supply chain product that moved forward as a prototype

Discovery for cell and gene therapy logistics: 5 days of fieldwork in US collection centres, and a product framed around orchestration and compliance.

Regulated · PharmaHealthcareCorporate innovation lab